Eyal Rubin

CIK 1721411 · Sr. VP and CFO · last filed 2024-11-05

Eyal Rubin is a Sr. VP and CFO who has filed 9 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for PLX, was dated Nov 5, 2024. Current disclosed insider exposure totals $1.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.61M

Companies

2

Total Filings

9

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
PLX	Sr. VP and CFO	660,909	$2.43	$1.61M	$0	8	2024-11-05
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Delisted	CFO and Treasurer	1,667	$0.75	$1.2K	$0	1	2017-11-20

Recent Filings

9 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2024-11-05	PLX	Grant (A)	+90,909	$0	EDGAR
2024-09-24	PLX	Grant (A)	+99,010	$0	EDGAR
2023-08-17	PLX	Grant (A)	+201,903	$0	EDGAR
2022-09-09	PLX	Grant (A)	—	$0	EDGAR
2022-02-28	PLX	Grant (A)	+121,951	$0	EDGAR
2020-08-14	PLX	Grant (A)	+246,146	$0	EDGAR
2020-08-13	PLX	Grant (A)	+246,146	$0	EDGAR
2019-09-24	PLX	Grant (A)	—	$0	EDGAR
2017-11-20	BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Delisted	Grant (A)	+25,000	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.